TRBV7-7

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, TRBV7-7 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated TRBV7-7 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher TRBV7-7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated TRBV7-7 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BRCA show a favorable association.

SKCM, UVM, and BRCA are the cancer types where TRBV7-7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMOSMedianAll0.3980.277<.00190view →
UVMOSTertileII,III,IV0.3020.661.00366view →
BRCAOSMedianII,III,IV0.6590.472.00148view →
PAADDFSTertileII,III,IV0.4110.245.00147view →
OVOSMedianIII,IV0.3660.270.00244view →
CESCOSTertileAll0.9010.739.00142view →
HNSCDFSQuartileAll0.7870.658.00134view →
KICHDFSTertileII,III,IV0.4320.880.02221view →
CHOLDFSQuartileAll0.7670.267.02318view →
LGGOSTertileAll0.2580.496.00718view →
THCADFSTertileII,III,IV0.9450.536.01618view →
LIHCDFSTertileAll0.6970.508.00418view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

TRBV7-7–SKCM (OS)

Kaplan–Meier survival curve for TRBV7-7 RNA-high vs -low samples in SKCM.

Open the SKCM breakdown →

Exploration